CHU de Nîmes - Hôpital Universitaire Carémea
Nîmes, 30029, France
NCT Number: NCT05890924
The frequency of violence against women, or intimate partner violence (IPV) is more and more underlined and recognized as a cofactor favoring certain somatic and psychic pathologies. However, its incidence in patients with venous thromboembolism (VTE) is unknown and its status as a risk factor is still elusive and ambiguous.
Investigators therefore conducted a matched case-control study consisting of women taking combined oral contraceptives (COC) who were investigated and followed up between 2010 and 2020.
The cases are the patients investigated for their first venous thromboembolic event, The controls were women free of thrombosis who had regular gynecological checkups. Case-control pairs were matched on region of residence, age (+/- 2 years), duration of COC intake (+/- 4 months), COC type (2nd, 3rd or 4th generation).
Looking for future studies?
Notify Me18 year and older
Female
Observational
Nîmes, 30029, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
WAST questionnaire, designed and validated as a screening tool for violence against women and intimate partner violence.
(ref: Brown JB, Lent B, Brett PJ, Sas G, Pederson LL. Development of the Woman Abuse Screening Tool for use in family practice. Fam Med. 1996 Jun;28(6):422-8.)
Time frame: inclusion
Self-administered questionnaire
Centre Hospitalier Universitaire de Nīmes
Other
(WAST-VTE) Intimate Partner Violence as a Risk Factor for Venous Thromboembolism in Women on Combined Oral Contraceptives: a Matched Case-control Study
Acronym: WAST-VTE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03945045
Cardiovascular Diseases, Catheter Mechanical Failure Rate
Taipei, Taiwan
View Trial DetailsNCT07699796
Cardiovascular Diseases, Embolism and Thrombosis
Fresno, California, United States
View Trial DetailsNCT04349189
Anemia, Anemia, Hemolytic
Bethesda, Maryland, United States
View Trial DetailsNCT02810704
Cardiovascular Diseases, Embolism
Scottsdale, Arizona, United States
View Trial Details